secwatch.observer — SEC 8-K summary
======================================

Issuer:     SQZ Biotechnologies Co (—)
CIK:        0001604477
Form:       8-K
Filed at:   2023-01-18T23:59:59+00:00
Accession:  0000950170-23-000875
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SQZ Biotechnologies receives NYSE non-compliance notice for stock price below $1.00
--------------------------------------------------------------------------------

- Received NYSE notice on Jan 18, 2023 for failing Section 802.01C: avg closing price below $1.00 over 30 days.
- No immediate delisting; company has a six-month cure period to regain compliance.
- Can cure if on last trading day of any month, closing price ≥ $1.00 and 30-day average ≥ $1.00.
- Considering alternatives including a reverse stock split, subject to stockholder approval.
- Stock continues to trade on NYSE during cure period, subject to other listing standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604477/000095017023000875/0000950170-23-000875-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604477/000095017023000875/sqz-20230118.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000875

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer